Biotechnology Portfolio Annual Yield vs. Net Asset
| FBIOX Fund | USD 19.74 0.69 3.38% |
For Biotechnology Portfolio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Biotechnology Portfolio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Biotechnology Portfolio Biotechnology utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Biotechnology Portfolio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Biotechnology Portfolio Biotechnology over time as well as its relative position and ranking within its peers.
Biotechnology |
Biotechnology Portfolio Net Asset vs. Annual Yield Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Biotechnology Portfolio's current stock value. Our valuation model uses many indicators to compare Biotechnology Portfolio value to that of its competitors to determine the firm's financial worth. Biotechnology Portfolio Biotechnology is one of the top funds in annual yield among similar funds. It also is one of the top funds in net asset among similar funds making up about 703,516,176,471 of Net Asset per Annual Yield. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biotechnology Portfolio's earnings, one of the primary drivers of an investment's value.Biotechnology Net Asset vs. Annual Yield
Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Biotechnology Portfolio |
| = | 0.01 % |
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Biotechnology Portfolio |
| = | 4.78 B |
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Biotechnology Net Asset Comparison
Biotechnology Portfolio is currently under evaluation in net asset among similar funds.
Biotechnology Portfolio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Biotechnology Portfolio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Biotechnology Portfolio will eventually generate negative long term returns. The profitability progress is the general direction of Biotechnology Portfolio's change in net profit over the period of time. It can combine multiple indicators of Biotechnology Portfolio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
The fund invests primarily in common stocks. It normally invests at least 80 percent of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuers financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.
Biotechnology Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Biotechnology Portfolio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Biotechnology Portfolio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Biotechnology Portfolio's important profitability drivers and their relationship over time.
Use Biotechnology Portfolio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biotechnology Portfolio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Portfolio will appreciate offsetting losses from the drop in the long position's value.Biotechnology Portfolio Pair Trading
Biotechnology Portfolio Biotechnology Pair Trading Analysis
The ability to find closely correlated positions to Biotechnology Portfolio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotechnology Portfolio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotechnology Portfolio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotechnology Portfolio Biotechnology to buy it.
The correlation of Biotechnology Portfolio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biotechnology Portfolio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biotechnology Portfolio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biotechnology Portfolio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Biotechnology Portfolio position
In addition to having Biotechnology Portfolio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Growth Funds Thematic Idea Now
Large Growth Funds
Funds or Etfs that invest in stocks of large-sized companies with above-average risk and growth rate. The Large Growth Funds theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Growth Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Biotechnology Mutual Fund
To fully project Biotechnology Portfolio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Biotechnology Portfolio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Biotechnology Portfolio's income statement, its balance sheet, and the statement of cash flows.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |